Letter by turc et Al regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials"

Stroke. 2015 Feb;46(2):e43-4. doi: 10.1161/STROKEAHA.114.007747. Epub 2015 Jan 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cerebral Hemorrhage / diagnosis*
  • Cerebral Hemorrhage / therapy*
  • Humans
  • Stroke / diagnosis*
  • Stroke / therapy*
  • Thrombolytic Therapy / methods*
  • Thrombolytic Therapy / standards*
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Tissue Plasminogen Activator